Hualan Biological Engineering Inc.
002007
Rangering i aksjer
#4386
Hualan Biological Engineering Inc. operates as a biopharmaceutical company,... Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. Its offerings span plasma-derived therapies, various viral and bacterial vaccines, recombinant proteins, and other advanced biologics. The company's extensive range of plasma products includes essential components like human albumin, a broad spectrum of human immunoglobulins (such as intravenous, rabies, hepatitis B, and tetanus formulations), and vital coagulation factors like human prothrombin complex and factor VIII. Hualan also provides specialized solutions such as lyophilized human thrombin for external use and surgical fibrin glue. In its vaccine division, Hualan offers critical immunizations, including several influenza vaccines (e.g., split virus, A H1N1, and quadrivalent forms), recombinant hepatitis B vaccine, and ACYW135 meningococcal polysaccharide vaccine. The company actively pursues strategic collaborations with key scientific organizations, most notably the Chinese Academy of Sciences, as well as other esteemed research institutes and enterprises. Established in 1992, Hualan Biological Engineering Inc. is headquartered in Xinxiang, People's Republic of China.
Aksjekurs
$1.92
Markedsverdi
$3.50B
Endring (1 dag)
-1.39%
Endring (1 år)
-19.45%
Land
CN
Handel Hualan Biological Engineering Inc. (002007)
Kategori
Healthcare
Utbyttehistorikk for Hualan Biological Engineering Inc. (002007)
Hualan Biological Engineering Inc. (aksjesymbol: 002007) har gitt totalt 22 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $4.00
Utbytteavkastning (TTM): 0.0781
Summen av alle utbytter (justert for aksjesplitt): $4.00
Utbytteavkastning (TTM): 0.0781
Utbyttebetalinger for Hualan Biological Engineering Inc. (002007) fra 2005 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $0.5 | -28.57% |
| 2025 | $0.7 | 133.33% |
| 2024 | $0.3 | 0.00% |
| 2023 | $0.3 | 50.00% |
| 2022 | $0.2 | -33.33% |
| 2021 | $0.3 | -25.00% |
| 2020 | $0.4 | 95.03% |
| 2019 | $0.2051 | 33.27% |
| 2018 | $0.1539 | -24.96% |
| 2017 | $0.2051 | 59.98% |
| 2016 | $0.1282 | -33.33% |
| 2015 | $0.1923 | 50.00% |
| 2014 | $0.1282 | 299.38% |
| 2013 | $0.0321 | -16.62% |
| 2012 | $0.0385 | -59.98% |
| 2011 | $0.0962 | 155.85% |
| 2010 | $0.0376 | 50.40% |
| 2009 | $0.025 | 19.62% |
| 2007 | $0.0209 | 15.47% |
| 2006 | $0.0181 | 24.83% |
| 2005 | $0.0145 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $0.5 | -28.57% |
| 2025 | $0.7 | 133.33% |
| 2024 | $0.3 | 0.00% |
| 2023 | $0.3 | 50.00% |
| 2022 | $0.2 | -33.33% |
| 2021 | $0.3 | -25.00% |
| 2020 | $0.4 | 95.03% |
| 2019 | $0.2051 | -31.63% |
| 2018 | $0.3 | -25.00% |
| 2017 | $0.4 | 0.00% |
| 2016 | $0.4 | -33.33% |
| 2015 | $0.6 | 50.00% |
| 2014 | $0.4 | 300.00% |
| 2013 | $0.1 | -16.67% |
| 2012 | $0.12 | -60.00% |
| 2011 | $0.3 | 60.00% |
| 2010 | $0.1875 | -6.25% |
| 2009 | $0.2 | 0.00% |
| 2007 | $0.2 | -36.00% |
| 2006 | $0.3125 | -16.67% |
| 2005 | $0.375 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 0.00% |
NL
|
|
| 30.00% |
BE
|
